A new study published today in *Nature* details a potentially game-changing advancement in diabetes treatment: a non-invasive method for delivering insulin through teh skin. Researchers have successfully used a “shuttle molecule” to transport insulin in animal models, offering a possible alternative to daily injections for the more than 37 million Americans living with diabetes [[source not provided in search results]]. The technique, tested on mice and miniature pigs, demonstrates successful absorption and comparable blood sugar regulation to conventional methods, raising hopes for a more agreeable and convenient future for those managing the disease.
Promising New Approach to Insulin Delivery Shows Success in Animal Trials
Researchers have demonstrated a potentially groundbreaking method for delivering insulin without injections, offering hope for a more comfortable and convenient treatment for people with Type 1 diabetes. The new technique utilizes a “shuttle molecule” to carry insulin through the skin, and early tests in mice and miniature pigs have yielded encouraging results.
The key to this innovation lies in attaching insulin to a molecule called OP, which facilitates its passage through the skin. Researchers tested the insulin-OP combination on mice and miniature pigs with Type 1 diabetes, applying it to the animals’ skin and tracking its absorption using a fluorescent marker. The study, published in Nature, found that the combination successfully crossed the skin barrier and entered the bloodstream.
“The fluorescence of the OP-insulin distributed throughout the entire skin within 30 minutes,” the researchers reported. As a result, blood sugar levels in the treated animals returned to normal within one to two hours – a timeframe comparable to that of traditional insulin injections. This non-invasive approach could significantly improve the quality of life for individuals managing diabetes, a condition affecting millions worldwide.
Extended Action and Targeted Delivery
Interestingly, the insulin delivered via the OP molecule appeared to have a longer-lasting effect compared to injected insulin. Researchers also observed that the OP-insulin accumulated in tissues like the liver, fat, and muscles – all of which play crucial roles in regulating blood sugar. This targeted delivery could potentially enhance the effectiveness of insulin therapy.
Importantly, the research team found no evidence of adverse effects. “The OP-insulin penetrated the skin completely non-invasively and without causing any irritation,” they stated. Repeated applications did not cause any structural changes to the skin, inflammation, or cell death.
Potential Beyond Diabetes
The researchers believe their discovery represents a promising pathway for non-invasive insulin delivery. “This could free patients with diabetes from subcutaneous injections,” they wrote. However, further studies are needed to ensure long-term safety and efficacy, and to determine the optimal dosage for individual patients before the technology can be used in humans.
If successful with insulin, this method could also be applicable to other protein- and peptide-based therapeutics that are currently too large to penetrate the skin. This opens up possibilities for delivering a wider range of medications without the need for injections.
Source: Nature
November 20, 2025
